September 27, 2013

Congress is expected to pass the Drug Quality and Security Act, which would subject sterile compounding pharmacies to stronger federal regulations and has attracted support from an independent pharmacy trade group, compared with a previous effort at federal regulations of compounding, Senate Bill 959, which many pharmacists feared would threaten their businesses and patients' access to compounded drugs. The efforts to place compounding pharmacies under federal regulations stem from last year's scandal in which many patients died and more were sickened after taking injected steroids contaminated with fungus.

The bills' purpose is simple enough: protecting the safety of patients by preventing irresponsible pharmacies like the New England Compounding Center from slipping through the cracks. But the older bill attracted opposition from independent pharmacies because, despite its good intentions, forced them to make costly changes to their business models or force them out of compounding altogether.

September 27, 2013

A bill designed to strengthen the security of the drug supply chain by creating an electronic track-and-trace system and national standards for sterile pharmacy compounding has attracted support from trade groups representing independent pharmacies and generic drug makers.

September 26, 2013

Legislation to allow the Food and Drug Administration to strengthen its regulatory powers over compounding pharmacies is expected to pass both houses of Congress after committees agreed on it Thursday, according to published reports.

September 25, 2013

A bill under consideration by the Senate could force more than 40% of compounding pharmacies to abandon compounding, according to a new survey.

September 6, 2013

The National Community Pharmacists Association on Thursday reiterated its stance on compounding to the House Energy and Commerce Committee of the U.S. House of Representatives.

August 20, 2013

Diplomat Specialty Pharmacy has appointed Cheryl Allen to VP business development and industry relations.

August 8, 2013

Can one of the nation's premier specialty pharmacies maintain its focus on each patient it serves while simultaneously smashing its own growth records and reaching national power-player status in the rarified world of specialized medication services?

August 2, 2013

The Senate was expected to take up a bill designed to secure the drug supply chain and establish a list of "do not compound" medications, but left for recess Friday without voting on it.

July 30, 2013

Big data finds another application and another supporter. Sort of.

The full Senate will shortly take up a new track-and-trace bill (S. 959), which would establish a national system for tracking the pedigree and movement of most pharmaceuticals, from point of manufacture and distribution to the dispensing pharmacy and the patient at the end of the supply chain. The goal: to replace the hodge-podge of different state laws with a single, nationwide track-and-trace system capable of capturing the daily flood of drug production, distribution, dispensing and utilization data and channeling it into an accessible tool by which stakeholders and regulators could secure the pharmaceutical supply chain.

July 30, 2013

Attendees of this year’s Cardinal Health Retail Business Conference will choose 1-of-3 finalists of a special best practice competition to determine the most innovative independent pharmacy program among Cardinal Health customers.

July 26, 2013

A new track-and-trace bill that the Senate is expected to consider would institute a nationwide "track-and-trace" system in place of patchwork state laws with the aim of securing the pharmaceutical supply chain.

July 16, 2013

The National Community Pharmacists Association CEO Douglas Hoey testified Tuesday before the U.S. House of Representatives Energy and Commerce Subcommittee on Health’s hearing on “Reforming the Drug Compounding Regulatory Framework.”

July 9, 2013

With some studies showing that patients' failure to take their medications as directed costs the economy nearly $300 billion per year, one group is looking to tackle what it sees as part of the problem: doctors' and pharmacists' instructions to patients on how much medicine to take and when.

June 19, 2013

The American Medical Association has officially recognized obesity as a disease, which could affect how healthcare professionals approach the issue, the group said at its annual meeting in Chicago.

June 17, 2013

Nina Shamayeva, owner of Austin Pharmacy in Forest Hills, N.Y., is launching a health initiative aimed at adults to "Help America be Pain-Free."

May 23, 2013

Aftershocks from last year's nationwide outbreak of fungal meningitis linked to a Massachusetts-based compounding pharmacy continued to be felt in a House subcommittee meeting Thursday.

May 9, 2013

One of the difficulties that federal regulators ran into during the nationwide scandal surrounding the New England Compounding Center — the Massachusetts-based pharmacy blamed for a nationwide fungal meningitis epidemic that has sickened hundreds and killed dozens — was the issue of when such pharmacies cross the line from compounding to manufacturing.

April 17, 2013

Food and Drug Administration commissioner Margaret Hamburg faced strong criticism Tuesday in a hearing before the House Committee on Energy and Commerce to investigate the nationwide outbreak of fungal meningitis linked to a Massachusetts compounding pharmacy, but she conceded the agency could have done more.

April 16, 2013

Two Dallas-based compounding pharmacies announced a recall of sterile drug products made at their facilities due to production conditions that could lead to contamination.

April 12, 2013

An inspection of more than two-dozen compounding pharmacies by Food and Drug Administration officials has found widespread problems with sanitation and sterilization practices, FDA commissioner Margaret Hamburg wrote in a blog post on the agency's website Thursday.

March 22, 2013

The commissioner of the Food and Drug Administration is renewing calls for legislation to give the agency more authority to regulate pharmacy compounding.

March 21, 2013

A compounding pharmacy in Georgia is recalling all of its sterile products following a Food and Drug Administration investigation that found possible lack of proper sanitation procedures, the FDA said.

March 11, 2013

A report on CBS' "60 Minutes" Sunday explored the aftermath of the nationwide outbreak of fungal meningitis linked to the New England Compounding Center that, according to the Centers for Disease Control and Prevention, has sickened 720 people in 20 states and led to 48 deaths.

March 4, 2013

The Food and Drug Administration will inspect about 30 compounding pharmacies that it has deemed "high risk," according to published reports.